文献速递主动脉疾病

开窗或分支腔内修复治疗夹层后胸腹主动脉瘤

Fenestrated or branched endovascular aortic repair for postdissection thoracoabdominal aortic aneurysm.
PubMed 文献 · J Vasc Surg · 2019-01-28

单中心回顾性分析20例夹层后胸腹主动脉瘤患者接受开窗或分支腔内修复(FB-EVAR),技术成功率100%,30天死亡率5%,脊髓缺血发生率10%。随访中6例需二次干预,假腔血栓化率1年达92%,动脉瘤直径回缩,总体生存率6个月95%、12和18个月均为88%。

要点

  • FB-EVAR治疗夹层后胸腹主动脉瘤技术可行,但围术期风险和再干预概率较高。
  • 术后1年假腔血栓化率92%,动脉瘤直径平均从术前71mm回缩至62mm。
  • 脊髓缺血发生率为10%,需关注围术期神经系统并发症。

核心结论

  • FB-EVAR对夹层后胸腹主动脉瘤可行,尽管存在围术期风险和较高的计划或非计划再干预概率,但能促进假腔血栓化和动脉瘤回缩。

研究设计与样本

  • 单中心回顾性分析2014年1月至2017年12月接受FB-EVAR的所有夹层后胸腹主动脉瘤患者,共20例,95%为男性,平均年龄64±9岁。

主要发现

  • 技术成功率100%,30天死亡率5%(1例),术后脊髓缺血2例(10%,部分性和完全性各1例)。
  • 中位随访12个月(范围0-31个月),6例需二次干预,包括胸主动脉支架内衬治疗III型内漏2例、主体与肾动脉支架连接处漏覆膜支架内衬2例、髂动脉假腔栓塞2例。
  • 完成1年随访CTA的12例患者动脉瘤平均直径术前、术后即刻、1年分别为71±18mm、66±19mm、62±19mm,相应假腔血栓化率分别为0%(0/20)、58%(7/12)、92%(11/12)。
  • 随访期间另1例死于非动脉瘤相关原因,估计总体生存率6个月95±5%、12个月88±8%、18个月88±8%。

临床怎么用

  • 对于夹层后胸腹主动脉瘤,FB-EVAR可作为促进主动脉重塑的可行选择,但需权衡围术期风险并计划密切随访和再干预。

局限性

  • 单中心回顾性研究,样本量小(20例),随访时间短(中位12个月),1年CTA完成率仅12/20。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Fenestrated or branched endovascular aortic repair (FB-EVAR) usually represents the last stage in endovascular treatment of postdissection aneurysm after thoracic endograft coverage of entry tear and false lumen embolization. METHODS: The study was a retrospective analysis of all patients with postdissection thoracoabdominal aneurysm treated with FB-EVAR in a single center. Short-term outcomes included technical success, operative mortality, and morbidities. Midterm outcomes included secondary intervention, false lumen thrombosis rate, aneurysm size regression, and subsequent survival. RESULTS: Twenty patients (95% male with a mean age of 64 ± 9 years) were treated between January 2014 and December 2017. The technical success was 100%. There was one death (5%) within 30 days. Postoperative complications included two patients with spinal cord ischemia (10%; one partial and one full). The median follow-up period was 12 months (range, 0-31 months). A secondary intervention was required in six patients, including thoracic stent graft relining for type III endoleak (n = 2), covered stent relining for junctional leak between main body and renal stent (n = 2), and iliac false lumen embolization (n = 2). Twelve patients completed the 1-year follow-up computed tomography angiogram, and their mean aneurysm diameters were 71 ± 18, 66 ± 19, and 62 ± 19 mm preoperatively, immediate postoperatively, and at 1 year, respectively; the corresponding false lumen thrombosis rates were 0% (0/20), 58% (7/12), and 92% (11/12), respectively. One more patient died during follow-up from a non-aneurysm-related cause. The estimated overall survival rates were 95 ± 5%, 88 ± 8%, and 88 ± 8% at 6, 12, and 18 months, respectively. CONCLUSIONS: FB-EVAR was feasible for postdissection thoracoabdominal aneurysm. Despite the associated perioperative risk and high probability of planned or unplanned reintervention, the procedure led to favorable aortic remodeling with false lumen thrombosis and aneurysm regression.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Law Y, Tsilimparis N, Rohlffs F, et al. Fenestrated or branched endovascular aortic repair for postdissection thoracoabdominal aortic aneurysm. J Vasc Surg. 2019. PMID: 30704800. doi:10.1016/j.jvs.2018.10.117

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。